US2017326191A1PendingUtilityA1

Molecular and Herbal Combinations for Treating Psoriasis

68
Assignee: SIRBAL LTDPriority: Nov 13, 2010Filed: May 29, 2017Published: Nov 16, 2017
Est. expiryNov 13, 2030(~4.3 yrs left)· nominal 20-yr term from priority
Inventors:Nadav Shraibom
A61K 36/65A61K 9/0019A61K 36/815A61K 36/64A61K 36/73A61K 36/804A61K 36/708A61K 36/355A61K 36/185
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of the above with Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A medicinal dosage composition for treating leukemia, lymphoma or breast cancer, or combinations thereof, comprising an active component consisting essentially of between three and seven herbs including a combination of Sheng Di Huang, Da Huang and Jin Yin Hua;
 wherein said active component comprises between approximately 18% and 90% of said Sheng Di Huang, between approximately 4% and 64% of said Da Huang, and between approximately 4% and 64% of said Jin Yin Hua, and   wherein said active component comprises at least approximately 60 wt. % of said combination.   
     
     
         2 . The medicinal dosage composition of  claim 1 , wherein the active component approximately comprises at least 40% of said Sheng Di Huang, at least 10% of said Da Huang, and at least 10% of said Jin Yin Hua. 
     
     
         3 . A treatment regimen including multiple medicinal dosage compositions for treating leukemia, lymphoma or breast cancer, or combinations thereof, comprising an active component consisting essentially of between three and seven herbs including a combination of Sheng Di Huang, Da Huang and Jin Yin Hua;
 wherein said active component comprises between approximately 18% and 90% of said Sheng Di Huang, between approximately 4% and 64% of said Da Huang, and between approximately 4% and 64% of said Jin Yin Hua, and   wherein said active component comprises at least approximately 60 wt. % of said combination, and   wherein said treatment regimen approximately includes at least 13.3 grams of the Sheng Di Huang, at least 3.3 grams of the Da Huang, and at least 3.3 grams of the Jin Yin Hua over a duration of said treatment regimen configured for administering as said multiple medicinal dosage compositions.   
     
     
         4 . The treatment regimen of  claim 3 , wherein the active component approximately comprises at least 40% of said Sheng Di Huang, at least 10% of said Da Huang, and at least 10% of said Jin Yin Hua. 
     
     
         5 . The treatment regimen of  claim 3 , wherein said active component comprises at least approximately 12% of said Jin Yin Hua. 
     
     
         6 . The treatment regimen of  claim 3 , wherein said multiple medicinal dosage compositions are configured for oral administration. 
     
     
         7 . The treatment regimen of  claim 3 , wherein said multiple medicinal dosage compositions are configured for subcutaneous administration. 
     
     
         8 . The treatment regimen of  claim 3 , wherein said active component comprises at least approximately 40% by weight of said Sheng Di Huang. 
     
     
         9 . The treatment regimen of  claim 3 , wherein said active component comprises at least 10% by weight of said Da Huang. 
     
     
         10 . The treatment regimen of  claim 3 , comprising at least 25 grams of the Sheng Di Huang, at least 10 grams of the Da Huang, and at least 10 grams of the Jin Yin Hua over a duration of said treatment regimen configured for administering as said multiple medicinal dosage compositions. 
     
     
         11 . The treatment regimen of  claim 3 , wherein the active component approximately comprises at least 50% of said Sheng Di Huang, at least 12.5% of said Da Huang, and at least 12.5% of said Jin Yin Hua. 
     
     
         12 . The treatment regimen of  claim 3 , wherein the active component comprises at least approximately 75 wt. % of said combination. 
     
     
         13 . The treatment regimen of  claim 3 , comprising 3.3-40 grams of Da Huang, 3.3-30 grams of Jin Yin Hua, and 13.3-60 grams of Sheng Di Huang. 
     
     
         14 . A method of preparing a treatment regimen that includes multiple medicinal dosage compositions for treating leukemia, lymphoma or breast cancer, or combinations thereof, comprising formulating combinations including Sheng Di Huang, Da Huang and Jin Yin Hua;
 wherein said combinations each comprise an active component consisting essentially of between three and seven herbs including between approximately 18% and 90% of said Sheng Di Huang, between approximately 4% and 64% of said Da Huang, and between approximately 4% and 64% of said Jin Yin Hua,   wherein said active component comprises at least approximately 60 wt. % of said combination,   wherein said treatment regimen approximately includes at least 13.3 grams of the Sheng Di Huang, at least 3.3 grams of the Da Huang, and at least 3.3 grams of the Jin Yin Hua configured for administering over a duration of said treatment regimen as said multiple medicinal dosage compositions.   
     
     
         15 . The method of  claim 14 , wherein said active component approximately comprises at least 40% of said Sheng Di Huang, at least 10% of said Da Huang, and at least 10% of said Jin Yin Hua. 
     
     
         16 . The method of  claim 14 , wherein the active component approximately comprises at least 40% of said Sheng Di Huang, at least 10% of said Da Huang, and at least 10% of said Jin Yin Hua. 
     
     
         17 . The method of  claim 14 , wherein the active component comprises at least approximately 12% of said Jin Yin Hua. 
     
     
         18 . The method of  claim 14 , wherein said multiple medicinal dosage compositions are configured for oral administration. 
     
     
         19 . The method of  claim 14 , wherein said multiple medicinal dosage compositions are configured for subcutaneous administration. 
     
     
         20 . The method of  claim 14 , wherein said active component comprises at least approximately 40% by weight of said Sheng Di Huang. 
     
     
         21 . The method of  claim 14 , wherein said active component comprises at least 10% by weight of said Da Huang. 
     
     
         22 . The method of  claim 14 , wherein said treatment regimen comprises at least 25 grams of the Sheng Di Huang, at least 10 grams of the Da Huang, and at least 10 grams of the Jin Yin Hua over a duration of said treatment regimen configured for administering as said multiple medicinal dosage compositions. 
     
     
         23 . The method of  claim 14 , wherein the active component approximately comprises at least 50% of said Sheng Di Huang, at least 12.5% of said Da Huang, and at least 12.5% of said Jin Yin Hua. 
     
     
         24 . The method of  claim 14 , wherein the active component comprises at least approximately 75 wt. % of said combination. 
     
     
         25 . The method of  claim 14 , comprising 3.3-40 grams of Da Huang, 3.3-30 grams of Jin Yin Hua, and 13.3-60 grams of Sheng Di Huang.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.